Large Molecular Weight Immunoreactive Corticotrophin‐Releasing Hormone has Bioactivity on Superfused Ovine Pituitary Cells
Open Access
- 1 February 1990
- journal article
- research article
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 2 (1) , 95-101
- https://doi.org/10.1111/j.1365-2826.1990.tb00399.x
Abstract
Human placental extracts fractionated with Sephadex G-50 produced three peaks of corticotrophin-releasing hormone immunoreactivity, a large molecular weight peak (Mr30,000), an intermediate peak (4,758 < Mr < 10,000) and a low molecular weight peak coeluting with the 41-residue hormone. All three peaks of immunoreactivity stimulated the release of β-endorphin-like immunoreactivity from ovine pituitary cells superfused in vitro. No response was observed from unstimulated cells superfused in parallel. Gel chromatography indicated that intermediate and small molecular weight forms of human corticotrophin-releasing hormone immunoreactivity remained intact after contact with the ovine pituitary cells, whereas the large molecular weight material dissociated to produce 41-residue hormone immunoreactivity. The secreted β-endorphin immunoreactivity was shown by gel chromatography to comprise both β-lipotrophin-like and the 31-residue β-endorphin-like immunoreactivity. The data show that the intermediate and low molecular weight forms of placental corticotrophin-releasing hormone immunoreactivity are bioactive and suggest that the intermediate form is a hormone precursor, possibly procorticotrophin-releasing hormone125–196, and the small form is identical to the hypothalamic hormone. The results with the larger molecular weight material indicate that it is likely to be a complex of the mature 41-residue hormone and a binding protein.Keywords
This publication has 24 references indexed in Scilit:
- Differential processing of corticotrophin-releasing hormone by the human placenta and hypothalamusBiochemical and Biophysical Research Communications, 1988
- The corticotropin releasing hormone gene is expressed in human placentaBiochemical and Biophysical Research Communications, 1987
- The use of reversed-phase high-performance liquid chromatography to detect proteolytic activity from human pancreas in a radioimmunoassay for corticotrophin-releasing factorJournal of Endocrinology, 1987
- Measurement of circulating corticotrophin-releasing factor in manJournal of Endocrinology, 1987
- Specific high-affinity binding protein for human corticotropin-releasing hormone in normal human plasmaBiochemical and Biophysical Research Communications, 1987
- Acute Hemorrhagic Stress in Conscious Sheep Elevates Immunoreactiveβ-Endorphin in Plasma but Not in Cerebrospinal Fluid*Endocrinology, 1986
- The Effect of Various Corticotropin-Releasing Factor Trains on the Release of Adrenocorticotropin,β-Endorphin, andβ-Lipotropin from Perifused Ovine Pituitary Cells*Endocrinology, 1985
- CRF-41 Stimulates the Release of β-Lipotrophin and β-Endorphin in Normal Human SubjectsNeuroendocrinology, 1984
- Human placental immunoreactive corticotropin, lipotropin, and beta-endorphin: evidence for a common precursor.Proceedings of the National Academy of Sciences, 1979